Verily’s chief medical officer Amy Abernethy is stepping down

Ngai Yeung

Health Tech Reporter

Verily’s chief medical officer and president of product development Amy Abernethy is leaving the company to build a healthcare nonprofit, the company told employees Tuesday …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Verily’s chief medical officer Amy Abernethy is stepping down

Ngai Yeung

Health Tech Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Trump 2.0 blog: Wayback Machine is insufficient for US health data, judge says

Travere plans to seek expanded label for kidney drug despite failed trial

Pfizer’s prostate cancer data leak shows promising results in early-stage study

What will pharma's share buyback shopping spree mean for M&A?

Biohaven lands priority review on second-chance application for neurodegenerative drug

Reducing risk in drug development: The importance of validated MRD testing in lymphoid cancers

Ver­i­ly’s chief med­ical of­fi­cer Amy Aber­nethy is step­ping down

Health Tech Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Verily’s chief medical officer Amy Abernethy is stepping down